Report Scope & Overview:
The Assisted Reproductive Technology Market is expected to reach USD 38.48 Bn by 2030 and was valued at USD 24.7 Bn in 2022 the CAGR growth rate will be 5.70% over the forecast period of 2023 -2030.
ART refers to medical procedures and strategies used to assist individuals or couples who are experiencing reproductive challenges in achieving pregnancy. These technologies are intended to make conception easier by modifying sperm, eggs, or embryos outside of the body before implanting them in the uterus. There are various types of ART procedures, each of which is meant to address a distinct reproductive issue One of the most prevalent ART techniques is in vitro fertilisation (IVF). It entails removing eggs from the ovaries, fertilising them in a laboratory dish with sperm, and then putting the resulting embryo(s) into the uterus. When there are challenges with egg quality, sperm quality, or other fertility issues, IVF is frequently employed.
.png)
ART has assisted countless couples and individuals in overcoming infertility and becoming pregnant. However, these treatments can be physically, emotionally, and financially taxing, and success rates can vary depending on factors such as age, underlying health issues, and the quality of the reproductive materials used. Anyone considering ART should speak with a medical practitioner to explore their options and select the best course of action based on their unique circumstances.
ART techniques are designed to address a variety of reproductive difficulties. There are various treatments available to meet individual situations, whether the problem is with the quality of eggs or sperm, fallopian tube blockages, or other reproductive problems.
Market Dynamics
Driver
The rising need of overcoming infertility.
The fundamental advantage of ART is that it gives a solution for infertile individuals and couples. It provides a mechanism for conceiving and carrying a pregnancy to term, even when standard approaches have failed.
Restrain
The high cost of the technology
Opportunity
The advancement in the technology
The growth of ART procedures has also led to advances in reproductive biology, genetics, and embryology. These breakthroughs have far-reaching ramifications for medical research and treatment.
Challenge
ART success rates might vary greatly based on factors such as age, underlying health issues, and reproductive material quality. Not every person or couple who undergoes ART will have a successful pregnancy.
Impact of Recession
Economic pressures may cause insurance coverage for fertility treatments to be lowered, making them less accessible to a larger population. Healthcare providers may also reduce their availability of specific services.
During difficult economic times, some individuals and couples may delay or opt not to undertake reproductive treatments, reducing demand for ART services. Impact on Research and Innovation: Recessions can result in lower financing for research and development, thereby slowing the advancement of novel reproductive technologies and therapies.
Impact of Russia Ukraine War
If the war causes travel restrictions, individuals or couples may find it more difficult to go to specific places for ART treatments, especially if they must cross borders. Travel may be discouraged as a result of safety concerns relating to the conflict.
During times of conflict, healthcare resources may be moved towards immediate medical needs, thereby limiting the availability of medical personnel and facilities for non-emergency treatments such as ART. Geopolitical conflicts can induce emotional stress and psychological suffering in communities that are directly affected by the conflict. Because of its possible impact on hormonal balance and overall health, stress may have an indirect impact on the success rates of ART operations.
Market Segmentation
By Type
In-Vitro Fertilization
Artificial Insemination
By End-Use Outlook
Fertility Clinics & Other Facilities
Hospitals & Care
.png)
Regional Coverage
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Key Players
The major key players are Cosmos Biomedical, Microm, CooperSurgical, Fujifilm Irvine Scientific, Cryolab, Vitrolife, European Sperm Bank, Bloom IVF Centre, Merck KGaA, Ferring B.V. and others.
CooperSurgical-Company Financial Analysis
Regional Analysis
The region of North America has well-established and advanced ART programmes. There is a high frequency of private fertility clinics that provide a wide range of therapies. Increased availability of third-party reproduction alternatives such as egg and sperm donation and surrogacy. In terms of technology and therapies, regulatory regimes are rather permissive.
Western European countries have robust ART programmes with diverse regulatory frameworks. Because of favourable rules, countries such as Spain and Greece are attractive destinations for reproductive tourism. Eastern European countries may have fewer facilities and a more limited range of services diverse countries have diverse cultural attitudes and regulatory regimes.
Recent Development
Micron- The company delivers industry’s fastest, highest-capacity HBM to advance generative AI Innovation,
CooperCompanies – The company has officially confirmed that it will be acquiring Cook Medicals reproductive business.
| Report Attributes | Details |
| Market Size in 2022 | US$ 24.7 Bn |
| Market Size by 2030 | US$ 38.48 Bn |
| CAGR | CAGR of 5.70 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (In-Vitro Fertilization, Artificial Insemination) • By End-Use Outlook (Fertility Clinics & Other Facilities, Hospitals & Care) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Cosmos Biomedical, Microm, CooperSurgical, Fujifilm Irvine Scientific, Cryolab, Vitrolife, European Sperm Bank, Bloom IVF Centre, Merck KGaA, Ferring B.V. |
| Key Drivers | • The rising need of overcoming infertility. |
| Market Restraints | • The high cost of the technology |
Ans. The Compound Annual Growth rate for Assisted Reproductive Technology Market over the forecast period is 5.70%.
Ans. The Assisted Reproductive Technology Market is expected to reach USD 38.48 Bn by 2030 and was valued at USD 24.7 Bn in 2022 the CAGR growth rate will be 5.70% over the forecast period of 2023 -2030.
Ans. The major key players are Cosmos Biomedical, Microm, CooperSurgical, Fujifilm Irvine Scientific, Cryolab, Vitrolife, European Sperm Bank, Bloom IVF Centre, Merck KGaA, Ferring B.V. and others.
Ans. North America is the fastest growing region of the Assisted Reproductive Technology Market.
Ans. The rising need of overcoming infertility
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Assisted Reproductive Technology Market Segmentation, by Type
8.1 In-Vitro Fertilization
8.2 Artificial Insemination
9. Assisted Reproductive Technology Market Segmentation, by End Use Outlook
9.1 Fertility Clinics & Other Facilities
9.2 Hospitals & Care
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Assisted Reproductive Technology Market by Country
10.2.2North America Assisted Reproductive Technology Market by Type
10.2.3 North America Assisted Reproductive Technology Market by End Use Outlook
10.2.4 USA
10.2.4.1 USA Assisted Reproductive Technology Market by Type
10.2.4.2 USA Assisted Reproductive Technology Market by End Use Outlook
10.2.5 Canada
10.2.5.1 Canada Assisted Reproductive Technology Market by Type
10.2.5.2 Canada Assisted Reproductive Technology Market by End Use Outlook
10.2.6 Mexico
10.2.6.1 Mexico Assisted Reproductive Technology Market by Raw Technology
10.2.6.2 Mexico Assisted Reproductive Technology Market by End Use Outlook
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Assisted Reproductive Technology Market by Country
10.3.1.2 Eastern Europe Assisted Reproductive Technology Market by Type
10.3.1.3 Eastern Europe Assisted Reproductive Technology Market by End Use Outlook
10.3.1.4 Poland
10.3.1.4.1 Poland Assisted Reproductive Technology Market by Type
10.3.1.4.2 Poland Assisted Reproductive Technology Market by End Use Outlook
10.3.1.5 Romania
10.3.1.5.1 Romania Assisted Reproductive Technology Market by Type
10.3.1.5.2 Romania Assisted Reproductive Technology Market by End Use Outlook
10.3.1.6 Hungary
10.3.1.6.1 Hungary Assisted Reproductive Technology Market by Type
10.3.1.6.2 Hungary Assisted Reproductive Technology Market by End Use Outlook
10.3.1.7 Turkey
10.3.1.7.1 Turkey Assisted Reproductive Technology Market by Type
10.3.1.7.2 Turkey Assisted Reproductive Technology Market by End Use Outlook
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Assisted Reproductive Technology Market by Type
10.3.1.8.2 Rest of Eastern Europe Assisted Reproductive Technology Market by End Use Outlook
10.3.2 Western Europe
10.3.2.1 Western Europe Assisted Reproductive Technology Market by Country
10.3.2.2 Western Europe Assisted Reproductive Technology Market by Type
10.3.2.3 Western Europe Assisted Reproductive Technology Market by End Use Outlook
10.3.2.4 Germany
10.3.2.4.1 Germany Assisted Reproductive Technology Market by Type
10.3.2.4.2 Germany Assisted Reproductive Technology Market by End Use Outlook
10.3.2.5 France
10.3.2.5.1 France Assisted Reproductive Technology Market by Type
10.3.2.5.2 France Assisted Reproductive Technology Market by End Use Outlook
10.3.2.6 UK
10.3.2.6.1 UK Assisted Reproductive Technology Market by Type
10.3.2.6.2 UK Assisted Reproductive Technology Market by End Use Outlook
10.3.2.7 Italy
10.3.2.7.1 Italy Assisted Reproductive Technology Market by Type
10.3.2.7.2 Italy Assisted Reproductive Technology Market by End Use Outlook
10.3.2.8 Spain
10.3.2.8.1 Spain Assisted Reproductive Technology Market by Type
10.3.2.8.2 Spain Assisted Reproductive Technology Market by End Use Outlook
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Assisted Reproductive Technology Market by Type
10.3.2.9.2 Netherlands Assisted Reproductive Technology Market by End Use Outlook
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Assisted Reproductive Technology Market by Type
10.3.2.10.2 Switzerland Assisted Reproductive Technology Market by End Use Outlook
10.3.2.11 Austria
10.3.2.11.1 Austria Assisted Reproductive Technology Market by Type
10.3.2.11.2 Austria Assisted Reproductive Technology Market by End Use Outlook
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Assisted Reproductive Technology Market by Type
10.3.2.12.2 Rest of Western Europe Assisted Reproductive Technology Market by End Use Outlook
10.4 Asia-Pacific
10.4.1 Asia Pacific Assisted Reproductive Technology Market by Country
10.4.2 Asia Pacific Assisted Reproductive Technology Market by Type
10.4.3 Asia Pacific Assisted Reproductive Technology Market by End Use Outlook
10.4.4 China
10.4.4.1 China Assisted Reproductive Technology Market by Type
10.4.4.2 China Assisted Reproductive Technology Market by End Use Outlook
10.4.5 India
10.4.5.1 India Assisted Reproductive Technology Market by Type
10.4.5.2 India Assisted Reproductive Technology Market by End Use Outlook
10.4.6 Japan
10.4.6.1 Japan Assisted Reproductive Technology Market by Type
10.4.6.2 Japan Assisted Reproductive Technology Market by End Use Outlook
10.4.7 South Korea
10.4.7.1 South Korea Assisted Reproductive Technology Market by Type
10.4.7.2 South Korea Assisted Reproductive Technology Market by End Use Outlook
10.4.8 Vietnam
10.4.8.1 Vietnam Assisted Reproductive Technology Market by Type
10.4.8.2 Vietnam Assisted Reproductive Technology Market by End Use Outlook
10.4.9 Singapore
10.4.9.1 Singapore Assisted Reproductive Technology Market by Type
10.4.9.2 Singapore Assisted Reproductive Technology Market by End Use Outlook
10.4.10 Australia
10.4.10.1 Australia Assisted Reproductive Technology Market by Type
10.4.10.2 Australia Assisted Reproductive Technology Market by End Use Outlook
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Assisted Reproductive Technology Market by Type
10.4.11.2 Rest of Asia-Pacific Assisted Reproductive Technology Market by End Use Outlook
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Assisted Reproductive Technology Market by Country
10.5.1.2 Middle East Assisted Reproductive Technology Market by Type
10.5.1.3 Middle East Assisted Reproductive Technology Market by End Use Outlook
10.5.1.4 UAE
10.5.1.4.1 UAE Assisted Reproductive Technology Market by Type
10.5.1.4.2 UAE Assisted Reproductive Technology Market by End Use Outlook
10.5.1.5 Egypt
10.5.1.5.1 Egypt Assisted Reproductive Technology Market by Type
10.5.1.5.2 Egypt Assisted Reproductive Technology Market by End Use Outlook
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Assisted Reproductive Technology Market by Type
10.5.1.6.2 Saudi Arabia Assisted Reproductive Technology Market by End Use Outlook
10.5.1.7 Qatar
10.5.1.7.1 Qatar Assisted Reproductive Technology Market by Type
10.5.1.7.2 Qatar Assisted Reproductive Technology Market by End Use Outlook
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Assisted Reproductive Technology Market by Type
10.5.1.8.2 Rest of Middle East Assisted Reproductive Technology Market by End Use Outlook
10.5.2 Africa
10.5.2.1 Africa Assisted Reproductive Technology Market by Country
10.5.2.2 Africa Assisted Reproductive Technology Market by Type
10.5.2.3 Africa Assisted Reproductive Technology Market by End Use Outlook
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Assisted Reproductive Technology Market by Type
10.5.2.4.2 Nigeria Assisted Reproductive Technology Market by End Use Outlook
10.5.2.5 South Africa
10.5.2.5.1 South Africa Assisted Reproductive Technology Market by Type
10.5.2.5.2 South Africa Assisted Reproductive Technology Market by End Use Outlook
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Assisted Reproductive Technology Market by Type
10.5.2.6.2 Rest of Africa Assisted Reproductive Technology Market by End Use Outlook
10.6 Latin America
10.6.1 Latin America Assisted Reproductive Technology Market by Country
10.6.2 Latin America Assisted Reproductive Technology Market by Type
10.6.3 Latin America Assisted Reproductive Technology Market by End Use Outlook
10.6.4 Brazil
10.6.4.1 Brazil Assisted Reproductive Technology Market by Type
10.6.4.2 Brazil Africa Assisted Reproductive Technology Market by End Use Outlook
10.6.5 Argentina
10.6.5.1 Argentina Assisted Reproductive Technology Market by Type
10.6.5.2 Argentina Assisted Reproductive Technology Market by End Use Outlook
10.6.6 Colombia
10.6.6.1 Colombia Assisted Reproductive Technology Market by Type
10.6.6.2 Colombia Assisted Reproductive Technology Market by End Use Outlook
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Assisted Reproductive Technology Market by Type
10.6.7.2 Rest of Latin America Assisted Reproductive Technology Market by End Use Outlook
11 Company Profile
11.1 Cosmos Biomedical
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Microm
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 CooperSurgical
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Fujifilm Irvine Scientific
11.4 Company Overview
11.4.2 Financials
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Cryolab
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Vitrolife
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 European Sperm Bank
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Bloom IVF Centre
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Merck KGaA
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Ferring B.V
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Report Scope & Overview: The Infusion Pump Software Market Size was valued at USD 924.28 million in 2022 and is expected to reach USD 1660 million by 2030 and grow at a CAGR of 7.6% over the forecast period 2023-2030.
Anxiety Disorders and Depression Treatment Market size was USD 11.26 Billion in 2022 and is expected to Reach USD 14.04 Billion by 2030 and grow at a CAGR of 2.8 % over the forecast period of 2023-2030.
The Nano Biotechnology Market Size was valued at USD 6.48 billion in 2022, and is expected to reach USD 13.79 billion by 2030 and grow at a CAGR of 9.9% over the forecast period 2023-2030.
The Consumer Healthcare market size was valued at USD 278 billion in 2022 and is expected to reach USD 492.12 billion by 2030 and grow at a CAGR of 7.4% over the forecast period of 2023-2030.
The 4D Printing in Healthcare Market Size was valued at USD 8.20 billion in 2022, and is expected to reach USD 14.96 billion by 2030, and grow at a CAGR of 7.8% over the forecast period 2023-2030.
The Nucleotide Market size was estimated USD 597.2 million in 2022 and is expected to reach USD 944.6 million by 2030 at a CAGR of 5.9% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2023 All Rights Reserved by SNS Insider Pvt Ltd
